ACS CAN has endorsed the Give Kids A Chance bill and has joined the Alliance for Childhood Cancer in calling on Congress to pass this legislation. The bill would restore import incentives to developing drugs for children with cancer.
As Congress and the administration consider changes to federal spending that could severely cut Medicaid funding and impact state budgets, some facts are getting lost in the debate.
Progress in improving childhood cancer outcomes relies on regular, federal investment in childhood cancer research, including continued funding for the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act and Childhood Cancer Data Initiative (CCDI).
